top of page

COVID-19 & Hematologic Malignancies: Episode 1 ~ 1.0 CNE

On Demand Webcast

OVERVIEW The COVID-19 pandemic has placed an unprecedented burden on both patients and healthcare workers in the United States, and clinicians who must manage the treatment of hematologic malignancies in this crisis are facing numerous unique challenges. Older individuals, as well as those with underlying health conditions, including cancer, are more likely to develop major complications with COVID-19.Healthcare providers for these patients must therefore ensure the continuation of appropriate oncologic care while minimizing the risk of exposure to SARS-CoV-2, the causative virus of COVID-19, or the development of severe complications from COVID-19. Guidance is only just starting to emerge regarding stopping, delaying, or modifying treatment for hematologic malignancies. Further, recommendations regarding the prevention, diagnostic testing, and treatment of COVID-19 are continuously evolving. Thus, in this rapidly changing and uncertain environment, it is vitally important that information is provided to clinicians that will help them continue to deliver essential care to these patients.

This webcast is a roundtable discussion with experts in lymphoma, myeloma, and infectious disease that aims to fill the gaps surrounding challenges faced by US healthcare practitioners as they manage the treatment of patients with hematologic malignancies in the midst of the COVID-19 pandemic.

LEARNING OBJECTIVES Upon successful completion of this educational activity, participants should be better able to:

  1. Describe the epidemiology, pathology and current treatment strategies of COVID-19

  2. Develop approaches to limit patient and provider exposure to SARS-CoV-2 while effectively managing hematologic malignancies

  3. Evaluate current COVID-19 treatment strategies for potential interactions with anticancer agents

  4. Identify, mitigate, and manage current and prospective diagnostic, therapeutic, and monitoring challenges in oncology care due to the reallocation of health resources as a result of the COVID-19 pandemic

CLAIMING CREDIT To be eligible for credit, participants must complete the online activity, a post-test assessment, and the evaluation by May 13, 2021. Upon completing the activity, there will be instructions on how to print a certificate or other documentation of credit. Release Date: May 13, 2020 Expiration Date: May 13, 2021 Estimated Time to Complete: 1.0 hour There is no fee associated with this activity.

7 views0 comments

Recent Posts

See All

Cancer Equity Colloquium 2024

Now more than ever, the presence of social inequities in healthcare is evident. This two-day, hybrid event, the Cancer Equity Colloquium, will address the diverse issues that underlie cancer inequitie


bottom of page